SPEXIS AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0542 CHF | -15.05% |
|
-8.14% | +32.20% |
| 05-01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
| 04-17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 0.0650 | 0.5500 | 0.4200 |
| Spread/Res. | -16.62% | -90.15% | -87.10% |
| Spread/Supp. | +6.27% | +62.28% | +59.41% |
| Support | 0.0510 | 0.0334 | 0.0340 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- POLN Stock
- Charts Spexis AG
